{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:51:17Z","timestamp":1778619077466,"version":"3.51.4"},"reference-count":17,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2012,5,25]],"date-time":"2012-05-25T00:00:00Z","timestamp":1337904000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0037891","type":"journal-article","created":{"date-parts":[[2012,5,25]],"date-time":"2012-05-25T21:43:57Z","timestamp":1337982237000},"page":"e37891","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast and Ovarian Cancer"],"prefix":"10.1371","volume":"7","author":[{"given":"Robert","family":"Pilarski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Weitzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terri","family":"McVeigh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jemima J.","family":"Dorairaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen M.","family":"Heneghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne B.","family":"Weidhaas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Kerin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xifeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Zelterman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Sand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee P.","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,5,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.","volume":"72","author":"A Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.","volume":"62","author":"D Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/gyno.2000.5895","article-title":"Patients with double primary tumors in the breast and ovary-clinical characteristics and BRCA1\u20132 mutations status.","volume":"79","author":"A Fishman","year":"2000","journal-title":"Gynecol Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/jmg.2009.075770","article-title":"BRCA1, BRCA2 and CHEK2 c.1100 delC mutations in patients with double primaries of the breasta and\/or ovaries.","volume":"47","author":"D Evans","year":"2010","journal-title":"J Med Genet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4149\/neo_2011_03_198","article-title":"BRCA1\/2 status and clinicopathologic characteristics of patients with double primary breast and ovarian cancer.","volume":"58","author":"M Cvelbar","year":"2011","journal-title":"Neoplasma"},{"key":"ref6","first-page":"1251","article-title":"Factors associated with decisions about clinical BRCA1\/2 testing.","volume":"9","author":"K Armstrong","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1200\/JCO.2009.25.6875","article-title":"Weighing options for cancer risk reduction in carriers of BRCA1 and BRCA2 mutations.","volume":"28","author":"Z Stadler","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.bjc.6604830","article-title":"Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation.","volume":"100","author":"K Metcalfe","year":"2009","journal-title":"Br J Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1158\/0008-5472.CAN-10-0689","article-title":"A KRAS-variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk.","volume":"15","author":"E Ratner","year":"2010","journal-title":"Cancer Research"},{"key":"ref10","article-title":"A 3&apos;-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis.","author":"T Paranjape","year":"2011"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"8535","DOI":"10.1158\/0008-5472.CAN-08-2129","article-title":"A SNP in a let-7 microRNA complementary site in the KRAS 3&apos; untranslated region increases non-small cell lung cancer risk.","volume":"68","author":"L Chin","year":"2008","journal-title":"Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/carcin\/bgp099","article-title":"A let-7 microRNA binding site polymorphism in the KRAS 3&apos;UTR is associatied with reduced survival in oral cancers.","volume":"30","author":"B Christensen","year":"2009","journal-title":"Carcinogenesis"},{"key":"ref13","article-title":"The role of <italic>KRAS<\/italic> rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.","volume":"8th","author":"P Pharoah","year":"2011","journal-title":"Clin Cancer Res online March"},{"key":"ref14","article-title":"A KRAS-variant is a Biomarker of Poor Outcome, Platinum Chemotherapy Resistance and a Potential Target for Therapy in Ovarian Cancer.","volume":"5","author":"E Ratner","year":"2011","journal-title":"Oncogene Dec"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.4161\/cc.10.11.15777","article-title":"MicroRNA signatures differentiate melanoma subtypes.","author":"E Chan","year":"2011"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.295.12.1379","article-title":"Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.","volume":"295","author":"T Walsh","year":"2006","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1158\/0008-5472.CAN-08-0599","article-title":"The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families.","volume":"68","author":"M Palma","year":"2008","journal-title":"Cancer Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0037891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T23:07:10Z","timestamp":1540508830000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0037891"}},"subtitle":[],"editor":[{"given":"Syed A.","family":"Aziz","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,5,25]]},"references-count":17,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0037891","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,25]]}}}